Home / Clusters / i-Health Innovative Medicine / Groups / HGUGM /
Español     RSS

HGUGM

Psiquiatría, Hospital General Universitario Gregorio Marañón

Publicaciones científicas

Scientific publications

Year Total IF average Q moda Internacionalization Agregation
2024 - - - - -
2023 - - - - -
2022 - - - - -
2021 - - - - -
2020 - - - - -
2019 - - - - -
2018 - - - - -
2017 - - - - -
2016 - - - - -
2015 - - - - -
2014 - - - - -
2013 19 4.725 Q1 10.53% -
2012 18 4.424 Q1 22.22% -
2011 23 5.139 Q1 17.39% -
2010 15 3.411 Q1 6.67% -
2009 15 7.515 Q1 13.33% -
Total 90 5.043 Q1 14.03% -

Principal categories: Psychiatry
Psychology, Developmental
Genetics & Heredity


Scientific publications linked to the cluster


In Press


  • Bioque, M.; García-Bueno, B.; Mac-Dowell, KS.; Meseguer, A.; Saiz, PA.; Parellada, M.; Gonzalez-Pinto, A.; Rodriguez-Jimenez, R.; Lobo, A.; Leza, JC.; Bernardo, M. Peripheral endocannabinoid system dysregulation in first-episode psychosis. Neuropsychopharmacology. (en prensa). (F.I.: 8.678).
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.678         Version PDF
  • de Portugal, E.; Díaz-Caneja, CM.; González-Molinier, M.; de Castro, MJ.; Del Amo, V.; Arango, C.; Cervilla, JA. Prevalence of premorbid personality disorder and its clinical correlates in patients with delusional disorder. Psychiatry Research. (en prensa).
    Category: Psychiatry       Quartile: 2º
    Impact factor: 2.456         Version PDF
  • Navas-Sánchez, FJ.; Alemán-Gómez, Y.; Sánchez-Gonzalez, J.; Guzmán-De-Villoria, JA.; Franco, C.; Robles, O.; Arango, C.; Desco, M. White matter microstructure correlates of mathematical giftedness and intelligence quotient. Human Brain Mapping. (en prensa).
    Category: Radiology, Nuclear Medicine & Medical Imaging       Quartile: 1º
    Impact factor: 6.878         Version PDF
  • Marder, SR.; Alphs, L.; Anghelescu, IG.; Arango, C.; Barnes, TR.; Caers, I.; Daniel, DG.; Duneyevich, E.; Fleischhacker, WW.; Garibaldi, G.; Green, MF.; Harvey, PD.; Kahn, RS.; Kane, JM.; Keefe, RS.; Kinon, B.; Leucht, S.; Lindenmayer, JP.; Malhotra, AK.; Stauffer, V.; Umbricht, D.; Wesnes, K.; Kapur, S.; Rabinowitz, J. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophrenia Research. (en prensa).
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Arango, C.; Garibaldi, G.; Marder, SR. Pharmacological approaches to treating negative symptoms: A review of clinical trials. Schizophrenia Research. (en prensa).
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590
  • Steinberg, S.; de Jong, S.; Mattheisen, M.; Costas, J.; Demontis, D.; Jamain, S.; Pietiläinen, OP.; Lin, K.; Papiol, S.; Huttenlocher, J.; Sigurdsson, E.; Vassos, E.; Giegling, I.; Breuer, R.; Fraser, G.; Walker, N.; Melle, I.; Djurovic, S.; Agartz, I.; Tuulio-Henriksson, A.; Suvisaari, J.; Lönnqvist, J.; Paunio, T.; Olsen, L.; Hansen, T.; Ingason, A.; Pirinen, M.; Strengman, E.; Hougaard, DM.; Orntoft, T.; Didriksen, M.; Hollegaard, MV.; Nordentoft, M.; Abramova, L.; Kaleda, V.; Arrojo, M.; Sanjuán, J.; Arango, C.; Etain, B.; Bellivier, F.; Méary, A.; Schürhoff, F.; Szoke, A.; Ribolsi, M.; Magni, V.; Siracusano, A.; Sperling, S.; Rossner, M.; Christiansen, C.; Kiemeney, LA.; Franke, B.; van den Berg, LH.; Veldink, J.; Curran, S.; Bolton, P.; Poot, M.; Staal, W.; Rehnstrom, K.; Kilpinen, H.; Freitag, CM.; Meyer, J.; Magnusson, P.; Saemundsen, E.; Martsenkovsky, I.; Bikshaieva, I.; Martsenkovska, I.; Vashchenko, O.; Raleva, M.; Paketchieva, K.; Stefanovski, B.; Durmishi, N.; Pejovic Milovancevic, M.; Lecic Tosevski, D.; Silagadze, T.; Naneishvili, N.; Mikeladze, N.; Surguladze, S.; Vincent, JB.; Farmer, A.; Mitchell, PB.; Wright, A.; Schofield, PR.; Fullerton, JM.; Montgomery, GW.; Martin, NG.; Rubino, IA.; van Winkel, R.; Kenis, G.; De Hert, M.; Réthelyi, JM.; Bitter, I.; Terenius, L.; Jönsson, EG.; Bakker, S.; van Os, J.; Jablensky, A.; Leboyer, M.; Bramon, E.; Powell, J.; Murray, R.; Corvin, A.; Gill, M.; Morris, D.; O'Neill, FA.; Kendler, K.; Riley, B; Wellcome Trust Case Control Consortium 2.; Craddock, N.; Owen, MJ.; O'Donovan, MC.; Thorsteinsdottir, U.; Kong, A.; Ehrenreich, H.; Carracedo, A.; Golimbet, V.; Andreassen, OA.; Børglum, AD.; Mors, O.; Mortensen, PB.; Werge, T.; Ophoff, RA.; Nöthen, MM.; Rietschel, M.; Cichon, S.; Ruggeri, M.; Tosato, S.; Palotie, A.; St Clair, D.; Rujescu, D.; Collier, DA.; Stefansson, H.; Stefansson K. Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry. (en prensa).
    Category: Psychiatry       Quartile: 1º
    Impact factor: 14.897         Version PDF
  • Caamaño, M.; Boada L.; Merchán-Naranjo, J.; Moreno, C.; Llorente, C.; Moreno, D.; Arango, C.; Parellada, M. Psychopathology in Children and Adolescents with ASD Without Mental Retardation. Journal of Autism and Developmental Disorders. (en prensa).
    Category: Psychology, Developmental       Quartile: 1º
    Impact factor: 3.723         Version PDF

2013


  • Parellada, M. Why psychogeriatrics starts right after adolescence. European Child and Adolescent Psychiatry, 22(7):391-3, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.699         Version PDF
  • Mac-Dowell, KS.; García-Bueno, B.; Madrigal, JLM.; Parellada, M.; Arango, C.; Micó, JA.; Leza, JC. Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation. International Journal of Neuropsychopharmacology, 16(1):121-35, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.641         Version PDF
  • de la Serna, E.; Andrés-Perpiñá, S.; Puig, O.; Baeza, I.; Bombin, I.; Bartrés-Faz, D.; Arango, C.; Gonzalez-Pinto, A.; Parellada, M.; Mayoral, M.; Graell, M.; Otero, S.; Guardia, J.; Castro-Fornieles, J. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia. Schizophrenia Research. 143(1):125-31, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Sánchez-Morla, EM.; Santos, JL.; Aparicio, A.; García-Jiménez, MA.; Soria, C.; Arango, C. Neuropsychological correlates of P50 sensory gating in patients with schizophrenia. Schizophrenia Research. 143(1):102-6, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Moreno, C.; Hasin, DS.; Arango, C.; Oquendo, MA.; Vieta, E.; Liu, S.; Grant, BF.; Blanco, C. The bipolar-depressive continuum in the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disorders, 15(1):112-113, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.621         Version PDF
  • Bernardo, M.; Bioque, M.; Parellada, M.; Saiz Ruiz, J.; Cuesta, MJ.; Llerena, A.; Sanjuán, J.; Castro-Fornieles, J.; Arango, C.; Cabrera, B; PEPs Group. Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Revista de Psiquiatría y Salud Mental, 6(1):4-16, 2013.
    Category: Psychiatry       Quartile: 4º
    Impact factor: 0.667         Version PDF
  • Bombin, I., Mayoral, M., Castro-Fornieles, J., Gonzalez-Pinto, A., de la Serna, E., Rapado-Castro, M., Barbeito, S., Parellada, M., Baeza, I., Graell, M., Payá, B., Arango, C. Neuropsychological evidence for abnormal neurodevelopment associated with early onset psychoses. Psychological Medicine, 43(4):757-68, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.587         Version PDF
  • Payá, B.; Rodríguez-Sánchez, JM.; Otero, S.; Muñoz, P.; Castro-Fornieles, J.; Parellada, M.; Gonzalez-Pinto, A.; Soutullo, C.; Baeza, I.; Rapado-Castro, M.; Sáenz-Herrero, M.; Moreno, D.; Arango, C. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder. Schizophrenia Research, 146(1-3):103-10, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Sanchez-Gistau, V.; Baeza, I.; Arango, C.; González-Pinto, A.; de la Serna, E.; Parellada, M.; Graell, M.; Paya, B.; Llorente, C.; Castro-Fornieles, J. Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. Journal of Clinical Psychiatry, 74(1):59-66, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.812         Version PDF
  • Nuevo, R.; Van Os, J.; Arango, C.; Chatterji, S.; Ayuso-Mateos, JL. Evidence for the early clinical relevance of hallucinatory-delusional states in the general population. Acta Psychiatrica Scandinavica, 127(6):482-493, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.857         Version PDF
  • Arango, C. Child neuropsychopharmacology: good news… the glass is half full. World Psychiatry, 12(2):128-9, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.974         Version PDF
  • Garcia-Amador, M.; de la Serna, E.; Vila, M.; Romero, S.; Valenti, M.; Sanchez-Gistau, V.; Benabarre, A.; Vieta E.; Castro-Fornieles, J. Parents with bipolar disorder: Are disease characteristics good predictors of psychopathology in offspring?. European Psychiatry, 28(4):240-6, 2013.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 3.285         Version PDF
  • de Portugal, E.; González, N.; del Amo, V.; Haro, JM.; Díaz-Caneja, CM.; Luna del Castillo, Jde D.; Cervilla, JA. Empirical redefinition of delusional disorder and its phenomenology: the DELIREMP study. Comprehensive psychiatry, 54(3):243-55, 2013.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 2.376         Version PDF
  • Noguera, A.; Ballesta, P.; Baeza I.; Arango, C.; de la Serna, E.; González-Pinto, A.; Parellada, M.; Graell, M.; Moreno, C.; Otero, S.; Castro-Fornieles, J. Twenty-Four Months of Antipsychotic Treatment in Children and Adolescents With First Psychotic Episode: Discontinuation and Tolerability. Journal of Clinical Psychopharmacology, 33(4):463-471, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.513         Version PDF
  • Torrent, C.; del Mar Bonnin, C.: Martinez-Arán, A.; del Valle, J.; Amann, B.; González-Pinto, A.; Crespo, JM; Ibañez, A.; Garcia-Portilla, MP.; Tabarés-Seisdedos, R.; Arango, C.; Colom, F.; Solé B.; Pacchiarotti, I.; Rosa, AR.; Ayuso-Mateos, JL; Anaya, C; Fernández, P.; Landín-Romero, R; Alonso, S.: Ortiz-Gil, A.; Segura, B.; Barbeito, S.; Vega, S.; Fernández, S.; Ugarte, A.; Subirà, A; Cerrillo, E.; Custal, N.; Menchón, JM.; Saiz-Ruiz, J.; Rodao, MJ.; Isella, S.; Alegría, A.; Al-Halabi, S.; Bobes, J.; Galván, G.; Saiz, PA.; Balanzá-Martínez, V.; Selva, G.; Fuentes-Durá, I.; Correa, P.; Mayoral, M.; Chiclana, G., Merchan-Naranjo, J., Rapado-Castro, M.; Salamero, M.; Vieta, E. Efficacy of Functional Remediation in Bipolar Disorder: A Multicentre, Randomized-Controlled Study. American Journal of Psychiatry, 170(8):852-9, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 14.721         Version PDF
  • Nutt, D.; Gispen-de Wied, CC.; Arango, C.; Keefe, RS.; Penadés, R.; Murphy, DG.; Robbins, TW.; Sahakian, BJ. Cognition in schizophrenia: Summary Nice Consultation Meeting 2012. European Neuropsychopharmacology, 23(8):769-78, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.595         Version PDF
  • Arango, C. To treat or not to treat? and How to treat? Two questions whose answers are far removed from evidence informed practice in child psychiatry. European Child and Adolescent Psychiatry, 22(9):521-2, 2013.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.699         Version PDF
  • Parellada, M.; Boada, L.; Moreno, C.; Llorente, C.; Romo, J.; Muela, C.; Arango, C. Specialty Care Programme for autism spectrum disorders in an urban population: A case-management model for health care delivery in an ASD population. European Psychiatry, 28(2):102-9, 2013.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 3.285         Version PDF
  • García-Bueno, B.; Bioque M.; Mac-Dowell, KS.; Barcones, MF.; Martínez-Cengotitabengoa, M.; Pina-Salvador-Carulla, L.; García-Gutiérrez, JC.; Ruiz Gutiérrez-Colosía, M.; Artigas-Pallarès, J.; García Ibáñez, J.; González Pérez, J.; Nadal Pla, M.; Aguilera Inés, F.; Isus, S.; Cereza, JM.; Poole, M.; Portero Lazcano, G.; Monzón, P.; Leiva, M.; Parellada, M.; García Nonell, K.; Martínez I Hernández, A.; Rigau, E.; Martínez-Leal, R. Borderline Intellectual Functioning: Consensus and good practice guidelines. Revista de Psiquiatría y Salud Mental, 6(3):109-20, 2013.
    Category: Psychiatry       Quartile: 4º
    Impact factor: 0.667         Version PDF

2012


  • Arango, C.; Rapado Castro, M.; Reig, S.; Castro-Fornieles, J.; González-Pinto, A.; Otero Cuesta, S.; Baeza, I.; Moreno, C.; Graell, M.; Janssen, J.; Parellada, M.; Moreno, D.; Bargalló, N.; Desco, M. Progressive brain changes in children and adolescents with first-episode psychosis. Archives of General Psychiatry, 69(1):16-26, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 13.772         Version PDF
  • Merchán-Naranjo, J.; Mayoral, M.; Rapado-Castro, M.; Llorente, C.; Boada, L.; Arango, C.; Parellada, M. Estimation of the Intelligence Quotient Using Wechsler Intelligence Scales in Children and Adolescents with Asperger Syndrome. Journal of Autism and Developmental Disorders, 42(1): 116-22, 2012.
    Category: Psychology, Developmental       Quartile: 1º
    Impact factor: 3.723         Version PDF
  • Parellada, M.; Moreno, C.; Mac-Dowell, K.; Leza, JC.; Giraldez, M.; Bailón, C.; Castro, C.; Miranda-Azpiazu, P.; Fraguas, D.; Arango, C. Plasma antioxidant capacity is reduced in Asperger syndrome. Journal of Psychiatric Research, 46(3):394-401, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.066         Version PDF
  • Janssen, J.; Aleman, Y.; Reig, S.; Schnack, H.; Parellada, M.; Graell, M.; Moreno, C.; Moreno, MD.; Mateos-Pérez, JM.; Udias, JM.; Arango, C.; Desco, M. Regional specificity of thalamic volume deficits in male adolescents with early-onset psychosis. British Journal of Psychiatry, 200: 30-6, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 6.606         Version PDF
  • Mayoral, M.; Bombín, I.; Castro-Fornieles, J.; González-Pinto, A.; Otero, S.; Parellada, M.; Moreno, D.; Baeza, I.; Graell, M.; Rapado, M.; Arango, C. Longitudinal study of neurological soft signs in first-episode early-onset psychosis. Journal of Child Psychology and Psychiatry, 53(3):323-31, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.422         Version PDF
  • Bobes, J.; Arango, C.; Aranda, P.; Carmena, R.; García-García, M.; Rejas, J.; on behalf of the CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study. European Psychiatry, 27(4): 267-274, 2012.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 3.285         Version PDF
  • Fischer, BA.; Keller, WR.; Arango, C.; Pearlson, GD.; McMahon, RP.; Meyer, WA.; Francis, A.; Kirkpatrick, B.; Carpenter, WT.; Buchanan, RW. Cortical structural abnormalities in deficit versus nondeficit schizophrenia. Schizophrenia Research, 136(1-3):51-4, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Moreno, C.; Hasin, DS.; Arango, C.; Oquendo, MA.; Vieta, E.; Liu, S.; Grant, BF.; Blanco, C. Depression in Bipolar versus Major Depression Disorder: Results from the National Epidemiological Survey on Alcohol and Related Conditions. Bipolar Disorders, 14(3): 271-82, 2012. (F.I.: 4.621).
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.621         Version PDF
  • Fraguas, D.; Gonzalez-Pinto, A.; Micó, JA.; Reig, S.; Parellada, M.; Martínez-Cengotitabengoa, M.; Castro-Fornieles, J.; Rapado-Castro, M.; Baeza, I.; Janssen, J.; Desco, M.; Leza, JC.; Arango, C. Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study. Schizophrenia Research, 137(1-3):58-65, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Nuevo, R.; Chatterji, S.; Verdes, E.; Naidoo, N.; Arango, C.; Ayuso-Mateos, JL. The Continuum of Psychotic Symptoms in the General Population: A Cross-national Study. Schizophrenia Bulletin, 38(3):475-85, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.486         Version PDF
  • Pina-Camacho, L.; Villero, S.; Fraguas, D.; Boada, L.; Janssen, J.; Navas-Sánchez, FJ.; Mayoral, M.; Llorente, C.; Arango, C.; Parellada, M. Autism Spectrum Disorder: Does Neuroimaging Support the DSM-5 Proposal for a Symptom Dyad? A Systematic Review of Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Studies. Journal of Autism and Developmental Disorders, 42(7):1326-41, 2012. (F.I.: 3.723).
    Category: Psychology, Developmental       Quartile: 1º
    Impact factor: 3.723         Version PDF
  • Arango, C. Someone is not listening to the facts: there is little psychiatry outside child and adolescent psychiatry. European Child and Adolescent Psychiatry, 21(9):475-6, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.699         Version PDF
  • Bobes, J.; García-Portilla, MP.; Bobes-Bascarán, MT.; Parellada, M.; Bascarán, MT.; Sáiz, P.; Bousoño, M.; Arango, C. The state of psychiatry in Spain. International Review of Psychiatry, 24(4): 347–355, 2012.
    Category: Psychiatry       Quartile: 3º
    Impact factor: 1.608         Version PDF
  • Merchán-Naranjo, J.; Tapia, C.; Bailón, C.; Moreno, C.; Baeza, I.; Calvo-Escalona, R.; Morer, A.; Martínez-Cantarero, C.; Nestares, PA.; Alda, JA.; Muñoz, D.; Arango, C. Secondary effects of antipsychotic treatment in naive or quasi-naive children and adolescents: Design of a follow-up protocol and baseline results. Revista de Psiquiatría y Salud Mental, 5(4):217-228, 2012.
    Category: Psychiatry       Quartile: 4º
    Impact factor: 0.667         Version PDF
  • Arango, C. Mental Health Research in Spain: A bit more than green shoots. Revista de Psiquiatría y Salud Mental, 5(4):211-213, 2012.
    Category: Psychiatry       Quartile: 4º
    Impact factor: 0.667         Version PDF
  • Parellada, M.; Moreno, C.; Moreno, M.; Espliego, A.; de Portugal, E.; Arango, C. Placebo effect in child and adolescent psychiatric trials. European Neuropsychopharmacology, 22(11):787-99, 2012.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.595         Version PDF
  • Gonzalez-Pinto, A.; Martinez-Cengotitabengoa, M.; Arango, C.; Baeza, I.; Otero-Cuesta, S.; Graell-Berna, M.; Soutullo, C.; Leza, JC.; Micó, JA. Antioxidant defense system and family environment in adolescents with family history of psychosis. BMC Psychiatry, 12(1):200, 2012.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 2.233         Version PDF
  • Irastorza, LJ.; Rojano, P.; Gonzalez-Salvador, T.; Cotobal, J.; Leira, M.; Rojas, C.; Rubio, G.; Rodríguez-Rieiro, C.; Bellon, JM.; Alvarez, M.; Rodríguez, C.; Arango, C. Psychometric properties of the Spanish version of the Diagnostic Interview for Depressive Personality. European Psychiatry, 27(8):582-90, 2012. (F.I.: 3.285).
    Category: Psychiatry       Quartile: 2º
    Impact factor: 3.285         Version PDF

2011


  • Arango, C.; Amador, X. Lessons learned about poor insight. Schizophrenia Bulletin, 37(1):27-8, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.486         Version PDF
  • Parellada, M.; Boada, L.; Fraguas, D.; Reig, S.; Castro-Fornieles, J.; Moreno, D.; Gonzalez-Pinto, A.; Otero, S.; Rapado-Castro, M.; Graell, M.; Baeza, I.; Arango, C. Trait and state attributes of insight in first Episodes of early-onset schizophrenia and other psychoses: A 2-year longitudinal study. Schizophrenia Bulletin, 37(1):38-51, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.486         Version PDF
  • Otero, S.; Moreno-Iniguez, M.; Payá, B.; Castro-Fornieles, J.; Gonzalez-Pinto, A.; Baeza, I.; Mayoral, M.; Graell, M.; Arango-López, C. Twelve-month follow-up of family communication and psychopathology in children and adolescents with a first psychotic episode (CAFEPS study). Psychiatry Research, 185(1-2):72-7, 2011.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 2.456         Version PDF
  • Ayuso-Mateos, JL.; Wykes, T.; Arango, C. The Madrid Declaration: why we need a coordinated European-wide effort in mental health research. British Journal of Psychiatry, 198:253-5, 2011. (F.I.: 6.606).
    Category: Psychiatry       Quartile: 1º
    Impact factor: 6.606         Version PDF
  • Mico, JA.; Rojas-Corrales, MO.; Gibert-Rahola, J.; Parellada, M.; Moreno, D.; Fraguas, D.; Graell, M.; Gil, J.; Irazusta, J.; Castro-Fornieles, J.; Soutullo, C.; Arango, C.; Otero, S.; Navarro, A.; Baeza, I.; Martinez-Cengotitabengoa, I.; Gonzalez-Pinto, A. Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry, 11(1):26, 2011.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 2.233         Version PDF
  • Arango, C. Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry. European Child and Adolescent Psychiatry, 20(2):67-70, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.699         Version PDF
  • González-Pinto, A.; de Azúa, SR.; Ibáñez, B.; Otero-Cuesta, S.; Castro-Fornieles, J.; Graell-Berna, M.; Ugarte, A.; Parellada, M.; Moreno, D.; Soutullo, C.; Baeza, I.; Arango, C. Can positive family factors be protective against the development of psychosis?. Psychiatry Research, 186(1):28-33, 2011.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 2.456         Version PDF
  • Robles, O.; Zabala, A.; Bombín, I.; Parellada, M.; Moreno, D.; Ruiz-Sancho, A.; Arango, C. Cognitive Efficacy of Quetiapine and Olanzapine in Early-Onset First-Episode Psychosis. Schizophrenia Bulletin, 37(2):405-15, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.486         Version PDF
  • Fatjó-Vilas, M.; Papiol, S.; Estrada, G.; Bombín, I.; Peralta, V.; Rosa, A.; Parellada, M.; Miret, S.; Martín, M.; Lázaro, L.; Campanera, S.; Muñoz, MJ.; Lera-Miguel, S.; Arias, B.; Navarro, ME.; Castro-Fornieles, J.; Cuesta, MJ.; Arango, C.; Fañanás, L. Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 156(3):323-33, 2011.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 3.231         Version PDF
  • González-Pinto, A.; Alberich, S.; Barbeito, S.; Gutierrez, M.; Vega, P.; Ibáñez, B.; Haidar, MK.; Vieta, E.; Arango, C. Cannabis and first-episode psychosis: Different long-term outcomes depending on continued or discontinued use. Schizophrenia Bulletin, 37(3):631-9, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.486         Version PDF
  • Desco, M.; Navas-Sanchez, FJ.; Sanchez-González, J.; Reig, S.; Robles, O.; Franco, C.; Guzmán-De-Villoria, J.; García-Barreno, P.; Arango, C. Mathematically gifted adolescents use more extensive and more bilateral areas of the fronto-parietal network than controls during executive functioning and fluid reasoning tasks. Neuroimage, 57(1): 281–92, 2011.
    Category: Neuroimaging       Quartile: 1º
    Impact factor: 6.252         Version PDF
  • Arango, C. Child and adolescent neuropsychopharmacology: Now or never. European Neuropsychopharmacology, 21(8):563-4, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.595         Version PDF
  • Fraguas, D.; Correll, CU.; Merchán-Naranjo, J.; Rapado-Castro, M.; Parellada, M.; Moreno, C.; Arango, C. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo controlled comparisons. European Neuropsychopharmacology, 21(8):621-45, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.595         Version PDF
  • Saiz, P.; García-Portilla, P.; Paredes, B.; Corcoran, P.; Arango, C.; Morales, B.; Sotomayor, E.; Álvarez, V.; Coto, E.; Flórez, G.; Bascarán, MT.; Bousoño, M.; Bobes, J. Role of serotonergic-related systems in suicidal behavior: Data from a case–control association study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(6): 1518–24, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.552         Version PDF
  • Arango, C. Physical comorbidity in mental illness in paediatric population: need for an integrated health care approach to paediatrics and child psychiatry. European Child and Adolescent Psychiatry, 20(8):379-80, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.699         Version PDF
  • Martínez-Martín, N.; Fraguas, D.; García-Portilla, MP.; Sáiz, PA.; Bascarán, MT.; Arango, C.; Bobes, J. Self-perceived needs are related to violent behavior among schizophrenia outpatients. Journal of Nervous and Mental Disease, 199(9):666-71, 2011.
    Category: Psychiatry       Quartile: 3º
    Impact factor: 1.842         Version PDF
  • Castro-Fornieles, J.; Baeza, I.; de la Serna, E.; Gonzalez-Pinto, A.; Parellada, M.; Graell, M.; Moreno, D.; Otero, S.; Arango, C. Two-year diagnostic stability in early-onset first-episode psychosis. Journal of Child Psychology and Psychiatry, 52(10):1089-98, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.422         Version PDF
  • Steinberg, S.; de Jong. S.; Irish Schizophrenia Genomics Consortium ; Andreassen, OA.; Werge, T.; Børglum, AD.; Mors, O.; Mortensen, PB.; Gustafsson, O.; Costas, J.; Pietiläinen, OP.; Demontis, D.; Papiol, S.; Huttenlocher, J.; Mattheisen, M.; Breuer, R.; Vassos, E.; Giegling, I.; Fraser, G.; Walker, N.; Tuulio-Henriksson, A.; Suvisaari, J.; Lönnqvist, J.; Paunio, T.; Agartz, I.; Melle, I.; Djurovic, S.; Strengman, E; GROUP; Jürgens, G.; Glenthøj, B.; Terenius, L.; Hougaard, DM.; Orntoft, T.; Wiuf, C.; Didriksen, M.; Hollegaard, MV.; Nordentoft, M.; van Winkel, R.; Kenis, G.; Abramova, L.; Kaleda, V.; Arrojo, M.; Sanjuán, J.; Arango, C.; Sperling, S.; Rossner, M.; Ribolsi, M.; Magni, V.; Siracusano, A.; Christiansen, C.; Kiemeney, LA.; Veldink, J.; van den Berg, L.; Ingason, A.; Muglia, P.; Murray, R.; Nöthen, MM.; Sigurdsson, E.; Petursson, H.; Thorsteinsdottir, U.; Kong, A.; Rubino, IA.; De Hert, M.; Réthelyi, JM.; Bitter, I.; Jönsson, EG.; Golimbet, V.; Carracedo, A.; Ehrenreich, H.; Craddock, N.; Owen, MJ.; O'Donovan, MC; Wellcome Trust Case Control Consortium ; Ruggeri, M.; Tosato, S.; Peltonen, L.; Ophoff, RA.; Collier, DA.; St Clair, D.; Rietschel, M.; Cichon, S.; Stefansson, H.; Rujescu, D.; Stefansson, K. Common Variants at VRK2 and TCF4 Conferring Risk of Schizophrenia. Human Molecular Genetics, 20(20):4076-81, 2011.
    Category: Genetics & Heredity       Quartile: 1º
    Impact factor: 7.692         Version PDF
  • Proal, E.; Alvarez-Segura, M.; de la Iglesia-Vayá, M.; Martí-Bonmatí, L.; Castellanos, FX.; Aguilar, EJ.; Cuerda, C.; Merchan-Naranjo, J.; Velasco, C.; Gutierrez, A.; Leiva, M.; de Castro MJ.; Parellada, M.; Giráldez, M.; Bretón, I.; Camblor, M.; García-Peris, P.; Dulín, E.; Sanz, I.; Desco, M.; Arango, C. Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics. Clinical Nutrition, 30(5):616-23, 2011.
    Category: Nutrition & Dietetics       Quartile: 2º
    Impact factor: 3.298         Version PDF
  • Reig, S.; Parellada, M.; Castro-Fornieles, J.; Janssen, J.; Moreno, D.; Baeza, I.; Bargalló, N.; González-Pinto, A.; Graell, M.; Ortuño, F.; Otero, S.; Arango, C.; Desco, M. Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis. Schizophrenia Bulletin, 37(6):1270-80, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.486         Version PDF
  • Arango, C.; Bobes, J.; Kirkpatrick, B.; Garcia-Garcia, M.; Rejas, J. Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study. European Neuropsychopharmacology, 21(12): 867–875, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.595         Version PDF
  • Nuevo, R.; Chatterji, S.; Fraguas, D.; Verdes, E.; Naidoo, N.; Arango, C.; Ayuso-Mateos, JL. Increased risk of diabetes mellitus among persons with psychotic symptoms: results from the WHO World Health Survey. Journal of Clinical Psychiatry, 72(12):1592-9, 2011.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.812         Version PDF
  • Canal-Bedia, R.; García-Primo, P.; Martín-Cilleros, MV.; Santos-Borbujo, J.; Guisuraga-Fernández, Z.; Herráez-García, L.; Herráez-García, M.; Boada-Muñoz, L.; Fuentes-Biggi, J.; Posada-de la Paz, M. Modified checklist for autism in toddlers: cross-cultural adaptation and validation in Spain. Journal of Autism and Developmental Disorders, 41(10):1342-51, 2011.
    Category: Psychology, Developmental       Quartile: 1º
    Impact factor: 3.723         Version PDF

2010


  • Sáiz, PA.; García-Portilla, MP.; Arango, C.; Morales, B.; Arias, B.; Corcoran, P.; Fernández, JM.; Álvarez, V.; Coto, E.; Bascarán, MT.; Bousoño, M.; Fañanas, L.; Bobes, J. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(1):26-31, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.552         Version PDF
  • de la Serna, E.; Mayoral, M.; Baeza, I.; Arango, C.; Andrés, P.; Bombin, I.; González, C.; Rapado, M.; Robles, O.; Rodríguez-Sánchez, JM.; Zabala, A.; Castro-Fornieles, J. Cognitive functioning in children and adolescents in their first episode of psychosis: Differences between previous cannabis users and nonusers. Journal of Nervous and Mental Disease, 198(2):159-162, 2010.
    Category: Psychiatry       Quartile: 3º
    Impact factor: 1.842         Version PDF
  • Rapado-Castro, M.; Soutullo, C.; Fraguas, D.; Arango, C.; Payá, B.; Castro-Fornieles, J.; González-Pinto, A.; Parellada, M.; Graell, M.; Baeza, I.; Bombin, I. Predominance of symptoms over time in early-onset psychosis: a principal component factor analysis of the Positive and Negative Syndrome Scale. Journal of Clinical Psychiatry, 71(3):327-37, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.799         Version PDF
  • Zabala, A.; Rapado, M.; Arango, C.; Robles, O.; de la Serna, E.; González, C.; Rodríguez-Sánchez, JM.; Andrés, P.; Mayoral, M.; Bombín, I. Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups. European Archives of Psychiatry and Clinical Neuroscience, 260(3): 225-33, 2010.
    Category: Psychiatry       Quartile: 2º
    Impact factor: 3.200         Version PDF
  • Bobes, J.; Arango, C.; Rejas, J.; for the CLAMORS Study Collaborative Group. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS Study. Journal of Clinical Psychiatry, 71(3):280-6, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.812         Version PDF
  • Moreno, C.; Merchán-Naranjo, J.; Álvarez, M.; Baeza, I.; Alda, JA.; Martínez-Cantarero, C.; Parellada, M.; Sánchez, B.; de la Serna, E.; Giráldez, M.; Arango, C. Metabolic effects of second-generation antipsychotics in bipolar youth: Comparison with other psychotic and non-psychotic diagnoses. Bipolar Disorders, 12(2):172-84, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.621         Version PDF
  • Bobes, J.; Arango, C.; García-García, M.; Rejas, J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophrenia Research, 119(1-3):101-109, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Santos, JL.; Sánchez-Morla, EM.; Aparicio, A.; García-Jiménez, MA.; Villanueva, C.; Martínez-Vizcaíno, V.; Arango, C. P50 gating in deficit and nondeficit schizophrenia. Schizophrenia Research, 119(1-3):183-190, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Saiz, PA.; Garcia-Portilla, MP.; Herrero, R.; Arango, C.; Corcoran, P.; Morales, B.; Bascarán, MT.; Alvarez, V.; Coto, E.; Paredes, B.; Fernández, JM.; Bobes, J. Interactions between functional serotonergic polymorphisms and demographic factors influence personality traits in healthy Spanish Caucasians. Psychiatric Genetics, 20(4):171-8, 2010.
    Category: Neurosciences       Quartile: 3º
    Impact factor: 2.365         Version PDF
  • Arango, C. Clinical subtyping and early detection: short-term challenges for child and adolescent psychiatry. European Child and Adolescent Psychiatry, 19(8): 627-8, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.699         Version PDF
  • Mayoral, M.; Merchán-Naranjo, J.; Rapado-Castro, M.; Leiva, M.; Moreno, C.; Giráldez, M.; Arango, C.; Parellada, M. Neurological soft signs in juvenile patients with Asperger syndrome, early-onset psychosis, and healthy controls. Early Intervention in Psychiatry, 4(4):283-90, 2010.
    Category: Psychiatry       Quartile: 3º
    Impact factor: 1.653         Version PDF
  • Fraguas, D.; Parellada, M.; Moreno, D.; Arango, C. Quetiapine treatment in adolescents: A 6-month naturalistic study. Revista de Psiquiatría y Salud Mental, 3(3): 106-110, 2010.
    Category: Psychiatry       Quartile: 4º
    Impact factor: 0.667         Version PDF
  • Fraguas, D.; Merchán-Naranjo, J.; Arango, C. Differential characteristics of the efficacy and tolerability of second-generation antipsychotics in the treatment of psychotic disorders in children and adolescents. Revista de Psiquiatría y Salud Mental, 3(4): 152-67, 2010.
    Category: Psychiatry       Quartile: 4º
    Impact factor: 0.667         Version PDF
  • Baharnoori, M.; Bartholomeusz, C.; Boucher, AA.; Buchy, L.; Chaddock, C.; Chiliza, B.; Föcking, M.; Fornito, A.; Gallego, JA.; Hori, H.; Huf, G.; Jabbar, GA.; Kang, SH.; El Kissi, Y.; Merchán-Naranjo, J.; Modinos, G.; Abdel-Fadeel, NA.; Neubeck, AK.; Ng, HP.; Novak, G.; Owolabi, OO.; Prata, DP.; Rao NP.; Riecansky, I.; Smith, DC.; Souza, RP.; Thienel, R.; Trotman, HD.; Uchida, H.; Woodberry, KA.; O'Shea, A. The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Schizophrenia Research, 124(1-3): e1-62, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Martínez Díaz-Caneja, C.; González-Molinier, M.; Conejo Galindo, J.; Moreno Iñiguez, M. Severe bowel ischemia due to clozapine with complete remission after withdrawal. Journal of Clinical Psychopharmacology, 30(4): 463-5, 2010.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.513         Version PDF

2009


  • Parellada, M.; Fraguas, D.; Bombín, I.; Otero, S.; Castro-Fornieles, J.; Baeza, I.; Gonzalez-Pinto, A.; Graell, M.; Soutullo, C.; Payá, B.; Arango, C. Insight correlates in child- and adolescent-onset first episodes of psychosis: results from the CAFEPS study. Psychological Medicine, 39(9):1433-45, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 5.587         Version PDF
  • Reig, S.; Moreno, C.; Moreno, D.; Burdalo, M.; Janssen, J.; Parellada, M.; Zabala, A.; Desco, M.; Arango, C. Progression of Brain Volume Changes in Adolescent-Onset Psychosis. Schizophrenia Bulletin, 35(1):233-43, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 8.486         Version PDF
  • Bobes, J.; Fillat, O.; Arango, C. Violence among schizophrenia outpatients compliant with medication: prevalence and associated factors. Acta Psychiatrica Scandinavica, 119(3):218-25, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.857         Version PDF
  • Moreno, D.; Moreno-Iñiguez, M.; Vigil, D.; Castro-Fornieles, J.; Ortuño, F.; González-Pinto, A.; Parellada, M.; Baeza, I.; Otero, S.; Graell, M.; Aldama, A.; Arango, C. Obstetric complications as a risk factor for first psychotic episodes in childhood and adolescence. European Child and Adolescent Psychiatry, 18(3):180-4, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.699         Version PDF
  • Saiz, PA.; García-Portilla, MP.; Florez, G.; Arango, C.; Corcoran, P.; Morales, B.; Bascaran, MT.; Alvarez, C.; San Narciso, G.; Carreño, E.; Alvarez, V.; Coto, E.; Bobes, J. Differential role of serotonergic polymorphisms in alcohol and heroin dependence. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 15; 33(4):695-700, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.552         Version PDF
  • Arango, C.; Robles, O.; Parellada, M.; Ruiz-Sancho, A.; Medina, O.; Zabala, A.; Bombín, I.; Moreno, MD. Olanzapine compared to quetiapine in adolescents with a first psychotic episode. European Child and Adolescent Psychiatry, 18(7):418-28, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 3.699         Version PDF
  • Goodwin, G.; Fleischhacker, W.; Arango, C.; Baumann, P.; Davidson, M.; de Hert, M.; Falkai, P.; Kapur, S.; Leucht, S.; Licht, R.; Naber, D.; O'Keane, V.; Papakostas, G.; Vieta, E.; Zohar, J. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. European Neuropsychopharmacology, 19(7):520-32, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.595         Version PDF
  • Balanzá-Martínez, V.; Cuesta, MJ.; Arango, C.; Crespo-Facorro, B.; Tabarés-Seisdedos, R. Longitudinal course of cognition in schizophrenia. British Journal of Psychiatry, 195(1):84, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 6.606         Version PDF
  • Stefansson, H.; Ophoff, RA.; Steinberg, S.; Andreassen, OA.; Cichon, S.; Rujescu, D.; Werge, T.; Pietiläinen, OP.; Mors, O.; Mortensen, PB.; Sigurdsson, E.; Gustafsson, O.; Nyegaard, M.; Tuulio-Henriksson, A.; Ingason, A.; Hansen, T.; Suvisaari, J.; Lonnqvist, J.; Paunio, T.; Børglum, AD.; Hartmann, A.; Fink-Jensen, A.; Nordentoft, M.; Hougaard, D.; Norgaard-Pedersen, B.; Böttcher, Y.; Olesen, J.; Breuer, R.; Möller, HJ.; Giegling, I.; Rasmussen, HB.; Timm, S.; Mattheisen, M.; Bitter, I.; Réthelyi, JM.; Magnusdottir, BB.; Sigmundsson, T.; Olason, P.; Masson, G.; Gulcher, JR.; Haraldsson, M.; Fossdal, R.; Thorgeirsson, TE.; Thorsteinsdottir, U.; Ruggeri, M.; Tosato, S.; Franke, B.; Strengman, E.; Kiemeney, LA.; Genetic Risk and Outcome in Psychosis (GROUP); Melle, I.; Djurovic, S.; Abramova, L.; Kaleda, V.; Sanjuan, J.; de Frutos, R.; Bramon, E.; Vassos, E.; Fraser, G.; Ettinger, U.; Picchioni, M.; Walker, N.; Toulopoulou, T.; Need, AC.; Ge, D.; Yoon, JL.; Shianna, KV.; Freimer, NB.; Cantor, RM.; Murray, R.; Kong, A.; Golimbet, V.; Carracedo, A.; Arango, C.; Costas, J.; Jönsson, EG.; Terenius, L.; Agartz, I.; Petursson, H.; Nöthen, MM.; Rietschel, M.; Matthews, PM.; Muglia, P.; Peltonen, L.; St Clair, D.; Goldstein, DB.; Stefansson, K.; Collier, DA. Common variants conferring risk of schizophrenia. Nature, 460(7256):744-7, 2009.
    Category: Multidisciplinary Sciences       Quartile: 1º
    Impact factor: 38.597         Version PDF
  • Vitiello, B.; Correll, C.; van Zwieten-Boot, B.; Zuddas, A.; Parellada, M.; Arango, C. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. European Neuropsychopharmacology, 19(9):629-35, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.595         Version PDF
  • Baeza, I.; Graell, M.; Moreno, D.; Castro-Fornieles, J.; Parellada, M.; González-Pinto, A.; Payá, B.; Soutullo, C.; de la Serna, E.; Arango, C. Cannabis use in children and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study). Schizophrenia Research, 113(2-3):129-137, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.590         Version PDF
  • Janssen, J.; Diaz-Caneja, A.; Reig, S.; Bombín, I.; Mayoral, M.; Parellada, M.; Graell, M.; Moreno, D.; Zabala, A.; Garcia-Vazquez, V.; Desco, M.; Arango, C. Brain morphology and neurological soft signs in adolescents with first-episode psychosis. British Journal of Psychiatry, 195(3):227-33, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 6.606         Version PDF
  • Sánchez-Morla, EM.; Santos, JL.; Aparício, A.; García-Jiménez, MA.; Villanueva, C.; Martínez-Vizcaíno, VM.; Arango, C. Antipsychotic effects on auditory sensory gating in schizophrenia patients. European Neuropsychopharmacology, 19(12):905-9, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 4.595         Version PDF
  • Janssen, J.; Reig, S.; Aleman, Y.; Schnack, H.; Udias, JM.; Parellada, M.; Graell, M.; Moreno D.; Zabala, A.; Balaban, E.; Desco, M.; Arango, C. Gyral and sulcal cortical thinning in adolescents with first episode early-onset psychosis. Biological Psychiatry, 66(11):1047-54, 2009.
    Category: Psychiatry       Quartile: 1º
    Impact factor: 9.247         Version PDF
  • Sáiz, PA.; García-Portilla, MP.; Florez, G.; Corcoran, P.; Arango, C.; Morales, B.; Leza, JC.; Álvarez, S.; Díaz, EM.; Álvarez, V.; Coto, E.; Nogueiras, L.; Bobes, J. Polymorphisms of the IL-1 gene complex are associated with alcohol dependence in spanish caucasians: Data from an association study. Alcoholism-Clinical and Experimental Research, 33(12):2147-53, 2009.
    Category: Substance Abuse       Quartile: 1º
    Impact factor: 3.421         Version PDF



TopTop

Members
39


Group imagen
Head:
Celso Arango López

UCM reference: 920186

Keywords:







Ministry of Education, Culture & Sports CEI Campus of International Excellence Ministry of Economy & Competitiveness
Funded project by the Ministry of Education, Culture & Sports, and the Ministry of Economy & Competitiveness within the framework of the Campus of International Excellence
Navigating this website constitutes acceptance of the use of cookies by third parties and own, necessary for proper operation.